|
KIAA1009 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.586200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.694800E-01 |
| Normal-vs-Stage2 |
8.597400E-01 |
| Normal-vs-Stage3 |
7.048200E-01 |
| Normal-vs-Stage4 |
2.836600E-01 |
| Stage1-vs-Stage2 |
8.123400E-01 |
| Stage1-vs-Stage3 |
7.730000E-01 |
| Stage1-vs-Stage4 |
5.885600E-01 |
| Stage2-vs-Stage3 |
9.476000E-01 |
| Stage2-vs-Stage4 |
6.010600E-01 |
| Stage3-vs-Stage4 |
4.876400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.391600E-01 |
| Normal-vs-AfricanAmerican |
5.562400E-01 |
| Normal-vs-Asian |
1.600810E-01 |
| Caucasian-vs-AfricanAmerican |
9.370800E-01 |
| Caucasian-vs-Asian |
1.903160E-01 |
| AfricanAmerican-vs-Asian |
1.744590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.919600E-01 |
| Normal-vs-Female |
9.703800E-01 |
| Male-vs-Female |
2.190200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.507600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.686400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.011400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.023400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.957400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.902800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.495600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.900000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.579800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.680000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.324100E-02 |
| Normal-vs-Grade 2 |
7.721400E-01 |
| Normal-vs-Grade 3 |
2.843000E-01 |
| Normal-vs-Grade 4 |
1.996210E-02 |
| Grade 1-vs-Grade 2 |
7.822000E-02 |
| Grade 1-vs-Grade 3 |
3.912400E-02 |
| Grade 1-vs-Grade 4 |
3.780600E-03 |
| Grade 2-vs-Grade 3 |
1.048970E-01 |
| Grade 2-vs-Grade 4 |
5.263000E-03 |
| Grade 3-vs-Grade 4 |
1.188800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.806200E-01 |
| Normal-vs-ccB subtype |
4.218100E-02 |
| ccA subtype-vs-ccB subtype |
6.573100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.908000E-01 |
| Normal-vs-N1 |
2.791400E-01 |
| N0-vs-N1 |
3.674000E-01 |
|
|
